SEC Form 4 · accession 0001209191-19-002933
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul W. Hoelscher
Officer — EVP, CFO
Period of report
Jan 4, 2019
Accepted (ET)
Jan 8, 2019 · 8:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jan 5, 2019 | M | 65,695 | — | A | 171,467 | D | |
| Ordinary Shares | Jan 5, 2019 | F | 29,419 | $20.39 | D | 142,048 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units (RSU)F1,F2 | — | Jan 4, 2019 | A | 53,948 | A | — | — | Ordinary Shares | 53,948 | 53,948 | D |
| Restricted Stock Units (RSU)F1,F3 | — | Jan 5, 2019 | M | 65,695 | D | — | — | Ordinary Shares | 65,695 | 131,392 | D |
Explanation of responses
- F1Each RSU represents a contingent right to receive one ordinary share of the Issuer.
- F2The RSU's vest 1/3rd annually on each anniversary of January 5, 2019.
- F3The RSU's vest 1/3rd annually on each anniversary of January 5, 2018.